Search dm+d | Analyse prescribing for this drug | See prices paid for this drug and its variants
| Name | Apremilast 10mg/20mg/30mg tablets treatment initiation pack |
| BNF code | 1001030AAAAABAB |
| Virtual Therapeutic Moiety | Apremilast |
| Basis of preferred name | Other |
| Date of name applicability | 16 Jan 2026 |
| Previous name | Generic Otezla tablets treatment initiation pack |
| Basis of previous name | Other |
| Reason for name change | Other |
| Combination product | Combination Product |
| Prescribing status | Valid as a prescribable product |
| Sugar free | ✗ |
| Gluten free | ✗ |
| Preservative free | ✗ |
| CFC free | ✗ |
| Dose form | Not applicable |
| Dose Form | |
|---|---|
| Formulation | Not applicable |
| Drug Route | |
| Route | Route of administration not applicable |
| Controlled Drug Prescribing Information | |
| Controlled Drug category | No Controlled Drug Status |
| Actual Medicinal Products | |
| Apremilast 10mg/20mg/30mg tablets treatment initiation pack (Aristo Pharma Ltd) | |
| Apremilast 10mg/20mg/30mg tablets treatment initiation pack (Genus Pharmaceuticals Ltd) | |
| Apremilast 10mg/20mg/30mg tablets treatment initiation pack (Teva UK Ltd) | |
| Otezla tablets treatment initiation pack (Amgen Ltd) | |
| Virtual Medicinal Product Packs | |
| Apremilast 10mg/20mg/30mg tablets treatment initiation pack 27 tablet | |
dm+d data retrieved from TRUD: release NHSBSA_2.0.0_20260202000001, imported on 3rd February 2026 at 04:14:48.